Prognostic Cancer Gene Expression Signatures: Current Status and Challenges

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Current cancer staging relies on anatomical extent, limiting personalized therapy.
• Biological parameters are needed to refine patient stratification for treatment and surveillance.
• Advances in genomics and big-data analytics enable detailed molecular tumor characterization.

Purpose of the Study:

• To review the current status of prognostic gene signatures in oncology.
• To explore the clinical relevance of gene expression signatures for patient stratification.
• To present challenges and future directions for gene signatures in breast, colorectal, and hepatocellular carcinoma.

Main Methods:

• Literature review of prognostic and predictive gene expression signatures.
• Analysis of the clinical implementation status of gene signatures.
• Focus on three major cancer types: breast, colorectal, and hepatocellular carcinoma.

Main Results:

• Numerous gene signatures show prognostic and predictive potential.
• Few gene signatures have achieved clinical implementation.
• Gene signatures offer a path towards biologically-defined tumor classification.

Conclusions:

• Prognostic gene signatures hold significant promise for improving cancer patient management.
• Further research and validation are crucial for clinical translation.
• Integrating molecular data into staging systems is essential for precision oncology.